Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if giving patients bevacizumab along with the
chemotherapy drugs oxaliplatin and gemcitabine will improve overall survival.
In addition, the study will find out what side effects patients may have by taking
bevacizumab, oxaliplatin, and gemcitabine together.
Phase:
Phase 2
Details
Lead Sponsor:
University of Oklahoma
Collaborators:
Genentech, Inc. M.D. Anderson Cancer Center Sanofi